Metabolic syndrome risk prediction in an Australian sample with first-episode psychosis using the psychosis metabolic risk calculator: A validation study
An updated and recalibrated PsyMetRiC model, PsyMetRiC-Australia, shows promise. Validation in a large sample is required to confirm its accuracy and clinical usefulness for the Australian population.
Authors
- Scott B. Teasdale (ORCID: https://orcid.org/0000-0001-6769-8421)
- Golam Mohammed Khandaker (ORCID: https://orcid.org/0000-0002-4935-9220)
- Rachel Morell (ORCID: https://orcid.org/0000-0003-3065-5318)
- Benjamin I. Perry (ORCID: https://orcid.org/0000-0002-1533-026X)
- Jackie Curtis (ORCID: https://orcid.org/0000-0001-6884-0098)
- Rachel Upthegrove (ORCID: https://orcid.org/0000-0001-8204-5103)
- Philip B. Ward (ORCID: https://orcid.org/0000-0002-5779-7722)
- Oliver Ardill‐Young (ORCID: https://orcid.org/0000-0002-7983-6999)
Institutions
- University of Cambridge (GB)
- Liverpool Hospital (AU)
- UNSW Sydney (AU)
- Centre for Mental Health (GB)
- University of Bristol (GB)
- Collaborative Neuroscience Network (US)
- Ingham Institute (AU)
- Cambridgeshire and Peterborough NHS Foundation Trust (GB)
- South Eastern Sydney Local Health District (AU)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- South Western Sydney Local Health District (AU)
- Mindgardens Neuroscience Network
- University of Birmingham (GB)
Publication Details
- Journal
- Australasian Psychiatry
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1177/10398562241269171
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care
- University of Bristol
- University of New South Wales
- Medical Research Council
- National Health and Medical Research Council